Latest stories on SCTX
Scribe Therapeutics reports Q2 EPS ($2.62), consensus ($3.72)
The Fly28 · bearishearnings
Scribe Therapeutics Inc. GAAP EPS of -$2.62 beats by $1.15, revenue of $1.92M misses by $1.19M
Seeking Alpha53 · neutralearnings
Scribe Therapeutics, Inc. (SCTX) files 8-K
SEC 8-K50 · neutralgeneral
Scribe Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
StockTitan50 · neutralgeneral
Scribe Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
GlobeNewswire56 · neutralproduct/pr
Scribe Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire56 · neutralgeneral
Scribe Therapeutics to Participate in Upcoming Investor Conferences
Business Insider56 · neutralgeneral
Scribe Therapeutics initiated with a Buy at H.C. Wainwright
The Fly61 · neutralanalyst
Leerink starts Scribe Therapeutics at Outperform on X-editor platform
The Fly61 · neutralanalyst
Scribe Therapeutics initiated with an Outperform at Leerink
The Fly61 · neutralanalyst
Scribe Therapeutics initiated with a Buy at Guggenheim
The Fly61 · neutralanalyst
Scribe Therapeutics initiated with an Overweight at Wells Fargo
The Fly63 · neutralanalyst
Guggenheim initiates Scribe Therapeutics stock with buy rating
Investing.com Analyst Ratings61 · neutralanalyst
Scribe Therapeutics initiated with Early-Stage Biotech at Goldman Sachs
The Fly56 · neutralanalyst
Scribe Therapeutics stock coverage initiated at Goldman Sachs
Investing.com Analyst Ratings56 · neutralanalyst
Cerbo Launches AI Scribe, a Native AI Charting Experience Built for Direct-Pay, Functional, and Integrative Medicine Practices
PR Newswire57 · neutralproduct/pr
SocGen Nears $5 Billion-Linked SRT Including Data Center Debt
Bloomberg48 · neutralgeneral
Scribe Therapeutics Updates Governance Following Initial Public Offering
TipRanks50 · neutralgeneral
Scribe Therapeutics, Inc. (SCTX) files 8-K
SEC 8-K50 · neutralgeneral
Scribe's Genetic Editing Aims to Prevent Heart Attacks
Barron's68 · bullishproduct/pr
Scribe Therapeutics raises $155.51M in IPO on Nasdaq
Investing.com Markets24 · bearishgeneral
Why is Scribe Therapeutics stock surging today?
Investing.com Markets50 · neutralgeneral
Eli Lilly and Sanofi-backed Scribe surges in public debut
Seeking Alpha78 · bullishearnings
Eli Lilly-Backed Scribe Therapeutics Soars 50% After IPO
Bloomberg78 · bullishearnings